Serum Institute asked to revise protocol for Covid-19 vaccine clinical trial

Serum Institute of India will perform an observer-blind, randomised controlled study enrolling at least 1,600 participants to determine the safety and immunogenicity of ‘Covishield’ for coronavirus treatment.

from Hindustan Times - india https://ift.tt/336FvK9